This new study investigated the relationship between cardiac function and hemodynamics among individuals presenting with heart failure with preserved ejection fraction (HFpEF) and normal levels of ...
Baseline N-terminal pro-brain natriuretic peptide (NT-proBNP) level appears to provide insights into the likelihood of symptomatic improvement after TAVR, a single-center study shows. Normal values ...
Wanting more data on the benefits of sacubitril/valsartan vs renin angiotensin system inhibitor background therapy, investigators conducted a large randomized study among persons with heart failure ...
Phase I study of sunitinib (S) in combination with metronomic dosing of cyclophosphamide and methotrexate (CM) in patients with metastatic breast cancer (MBC) No significant financial relationships to ...
The inactive N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) has been linked to ventricular dysfunction in the general population, and is predictive of cardiac events. Corteville et ...
Healthy people—especially women—with elevated levels of the heart failure marker NT-proBNP have a lower risk of developing type 2 diabetes. However, if these people develop diabetes nonetheless, they ...
Please provide your email address to receive an email when new articles are posted on . Empagliflozin was safe and effective in patients with HF with reduced ejection fraction regardless of systolic ...
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a key test in primary care to inform which people with ...
Please provide your email address to receive an email when new articles are posted on . Cancer survivors with increased NT-proBNP levels had an elevated risk for all-cause and cardiac mortality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results